Drug Interactions9 min readUpdated 2026-04-03

    GLP-1 and Lamictal (Lamotrigine): Interaction Guide for Bipolar and Seizure Patients

    Can you safely take GLP-1 medications with Lamictal? Guide to semaglutide/tirzepatide and lamotrigine interactions, absorption concerns, and managing both medications.

    Key Takeaway

    No direct interaction. Lamictal is weight-neutral, making it a favorable mood stabilizer for GLP-1 users. Main concern is ensuring Lamictal absorption is not affected by GLP-1-related vomiting. Time doses separately.

    Safety Considerations

    Lamotrigine is used for bipolar disorder maintenance, seizure prevention, and sometimes depression. It is one of the most weight-friendly psychiatric medications, making it an excellent choice for patients also using semaglutide or tirzepatide for weight management.

    Favorable Combination

    Unlike many psychiatric medications, Lamictal does not cause weight gain, metabolic syndrome, or insulin resistance. This makes the GLP-1 + Lamictal combination particularly straightforward, as you are not fighting medication-induced weight gain.

    Absorption Timing

    If GLP-1 nausea causes vomiting, take Lamictal at a time when nausea is least likely. For most patients, this means taking Lamictal in the morning if GLP-1 injection was the previous evening, or vice versa. Consistent absorption is important for seizure and mood control.

    Skin Monitoring

    Lamotrigine carries a rare risk of serious skin reactions (Stevens-Johnson syndrome). Starting GLP-1 medication should not affect this risk, but any new rash while on Lamictal should be reported immediately, regardless of other medication changes.

    Managing Both Medications

    Best Practices

    • Time Lamictal away from peak GLP-1 nausea
    • Monitor mood stability during weight loss
    • Keep consistent Lamictal timing
    • Inform both providers of all medications

    Watch For

    • Seizure breakthrough or mood destabilization
    • Vomiting within 2 hours of Lamictal dose
    • Any new rash (always urgent with Lamictal)
    • Rapid mood cycling during weight changes

    Medical Disclaimer: This content is for informational purposes only. Never adjust Lamictal dosing without your prescriber. Report any rash immediately. Seizure medication management requires professional oversight.

    Frequently Asked Questions

    Can I take GLP-1 medications with Lamictal?

    No direct pharmacological interaction exists between GLP-1 medications and lamotrigine. However, GLP-1 delayed gastric emptying could theoretically affect lamotrigine absorption timing. Lamotrigine is well-absorbed regardless of food, so clinical impact is expected to be minimal. Monitor seizure control and mood stability.

    Is Lamictal weight-neutral?

    Lamotrigine is one of the few mood stabilizers/anticonvulsants considered weight-neutral or even associated with modest weight loss. Patients on Lamictal often need GLP-1 medications for other reasons (prior weight gain from other medications, metabolic conditions, or baseline obesity) rather than Lamictal-induced weight gain.

    Could GLP-1 vomiting affect my Lamictal levels?

    Yes, if you vomit within 1-2 hours of taking Lamictal, the dose may not be fully absorbed. This is especially concerning because sub-therapeutic lamotrigine levels can trigger seizures or mood episodes. Take Lamictal at a different time than when GLP-1 nausea is likely worst.

    Does weight loss affect Lamictal effectiveness?

    Lamotrigine dosing is not typically weight-based in adults, so moderate weight loss should not significantly affect therapeutic levels. However, major body composition changes can alter drug distribution. Continue regular monitoring of symptoms and levels if applicable.

    GLP-1 Treatment with Full Medication Review

    Compounded semaglutide from $99/mo or tirzepatide from $125/mo.

    View Treatment Options

    Sources & References

    1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
    2. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
    3. Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
    4. FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).

    Can I take Lamictal with semaglutide or tirzepatide?

    Lamotrigine (Lamictal) and GLP-1 receptor agonists (semaglutide, tirzepatide) can be co-prescribed without absolute contraindication, but require coordination with your prescribing psychiatrist or neurologist. Per FDA Wegovy, Ozempic, Mounjaro, and Zepbound prescribing information, no direct pharmacokinetic interaction is documented with lamotrigine. Mechanism concern: GLP-1-induced delayed gastric emptying may slightly affect oral lamotrigine absorption timing, but no clinically significant change in serum lamotrigine levels has been documented in clinical trials or post-marketing surveillance. Important caveat: lamotrigine has a relatively narrow therapeutic window — it requires gradual dose titration to avoid Stevens-Johnson syndrome (a serious skin reaction more likely at supratherapeutic plasma levels). If GLP-1 therapy theoretically alters lamotrigine pharmacokinetics, this could matter for patients on borderline therapeutic levels. Recommended approach: maintain consistent lamotrigine dosing schedule (don't change timing on GLP-1 injection day), monitor for any new skin rash during the first 8-12 weeks on GLP-1 and report to clinician immediately, some prescribing clinicians recommend baseline lamotrigine plasma level before starting GLP-1 + recheck after 8-12 weeks for patients with seizure disorders or bipolar disorder where stable mood control is critical. Any new skin rash on lamotrigine — regardless of GLP-1 use — warrants urgent medical evaluation due to Stevens-Johnson syndrome risk. Discuss with both your GLP-1 prescriber (Trimi/Beluga clinician) and your psychiatrist/neurologist before initiating combination.

    No direct interaction; coordinate with psychiatrist/neurologist.
    Lamotrigine narrow therapeutic window; monitor for skin rash.
    Some recommend baseline + 8-12 wk plasma level check.

    Key Takeaways

    • Lamotrigine (Lamictal) is FDA-approved anticonvulsant for epilepsy and bipolar disorder; commonly used long-term in bipolar maintenance.
    • No direct pharmacokinetic interaction with semaglutide or tirzepatide per FDA Wegovy/Ozempic/Mounjaro/Zepbound prescribing information.
    • Mechanism concern: GLP-1's delayed gastric emptying may slightly affect oral lamotrigine absorption timing, but no clinically significant change in serum levels documented.
    • Important: lamotrigine has narrow therapeutic window with risk of Stevens-Johnson syndrome at supratherapeutic levels — monitor for skin rash on starting GLP-1 if levels could theoretically shift.
    • Coordinate with prescribing psychiatrist or neurologist; some clinicians recommend baseline lamotrigine level + recheck after 8-12 weeks on GLP-1.

    Medically Reviewed

    DMR

    Dr. Michael Rodriguez

    MD, FACP, Board Certified in Internal Medicine

    Internal Medicine & Weight Management

    Last reviewed: March 20, 2026

    TCCT

    Written by Trimi Clinical Content Team

    Medical Writers & Healthcare Professionals

    Our clinical content team includes registered nurses, pharmacists, and medical writers who specialize in translating complex medical information into clear, actionable guidance for patients.

    Medically reviewed by Dr. Michael Rodriguez, MD, FACP, Board Certified in Internal Medicine

    What real Trimi patients say

    Verbatim quotes from Trimi's Facebook and Reddit community reviews. First name and last initial preserved per editorial policy.

    Amazing company and care team support! Fast response time, no hidden fees and they actually care enough to work with you and your needs on your weight loss journey. Down 12.5 pounds in 2 months!

    Outcome: Down 12.5 lbs in 2 months

    Sarah MillerFacebook
    Arrived within 24 hours. Easy to use. Comes with everything. The year is so worth it.

    Outcome: Same-day delivery experience

    Veronica LarimoreFacebook

    Editorial Standards

    Trimi publishes patient education using a medical-review workflow, source-based claim checks, and dated updates for fast-changing pricing, access, and safety topics.

    Review our Editorial Policy and Medical Review Policy for more details about sourcing, updates, and reviewer attribution.

    Scientific References

    1. Novo Nordisk (2025). Wegovy (semaglutide) prescribing information. U.S. Food and Drug Administration.Read Study
    2. Eli Lilly and Company (2025). Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration.Read Study
    3. The Endocrine Society (2024). Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism.Read Study
    4. American Association of Clinical Endocrinology (2024). AACE Comprehensive Type 2 Diabetes Management Algorithm — Obesity. Endocrine Practice.Read Study

    Was this article helpful?

    Keep Reading

    Can you safely take GLP-1 medications with Effexor? Guide to semaglutide/tirzepatide and venlafaxine interactions, weight gain concerns, and managing both medications together.

    Can you take semaglutide or tirzepatide with Prozac? Complete guide to GLP-1 and fluoxetine interactions, weight effects, safety considerations, and what to discuss with your doctor.

    Can you take GLP-1 medications with Vyvanse? Guide to semaglutide/tirzepatide and lisdexamfetamine interactions, appetite effects, and managing ADHD with weight loss treatment.

    Can you take GLP-1 medications with Concerta? Guide to semaglutide/tirzepatide and methylphenidate interactions, combined appetite effects, and managing both safely.

    Start your GLP-1 journey — from $99/mo

    Get Started